logo

Newlink Genetics (NLNK)



Trade NLNK now with
  Date
  Headline
4/2/2019 8:18:23 AM NewLink Genetics Presents Encouraging Phase 2 Results For NLG207 In Ovarian Cancer At AACR 2019
11/15/2018 9:13:52 AM NewLink Genetics Says Merck Begins Rolling Submission Of Licensure Application For Ebola Vaccine V920 To FDA
7/2/2018 8:08:11 AM NewLink Genetics Presents Positive Updated Phase 1 Data With Indoximod Plus Radio-Immunotherapy
4/15/2018 5:01:05 PM NewLink Genetics Announces Initial Phase 1 Data With Indoximod Plus Radiation And Chemotherapy
4/6/2018 3:03:01 PM NewLink Genetics Announces Review Of Clinical Programs
1/8/2018 8:25:35 AM NewLink Genetics Updates Clinical And Financial Guidance
6/5/2012 7:24:50 AM Robert W. Baird Reiterates NewLink Genetics (NLNK) At Outperform With $17 Price Target
3/30/2012 7:39:57 AM Robert W. Baird Reiterates NewLink Genetics (NLNK) At Outperform With $10 Price Target
12/21/2011 7:38:34 AM Robert W. Baird Initiates NewLink Genetics (NLNK) At Outperform With $10 Price Target
  
 
>